FocusRegulatory Science

Balancing Tissue and Tumor Formation in Regenerative Medicine

See allHide authors and affiliations

Science Translational Medicine  15 Aug 2012:
Vol. 4, Issue 147, pp. 147fs28
DOI: 10.1126/scitranslmed.3003685


A set of general principles can guide preclinical testing strategies for evaluating the tumorigenicity of regenerative medicine products.

View Full Text